Piramal Pharma Stake Sale On Track, Gains Seen For Contract Business Amid Pandemic

Piramal Enterprises, which is in the process of fund raising for its pharma business, says it's well geared to cater to evolving requirements in the sector amid COVID-19 given its global manufacturing footprint with a strong compliance record. Pharma, the Indian firm’s management maintains, is one of the ‘safest and most resilient’ industries in the current uncertainty.

Trees
Piramal To Bring In Minority Investor For Pharma Business • Source: Shutterstock

India's Piramal Enterprises Ltd. (PEL) has indicated that the potential sale of a stake in the group’s pharma business is on course and incoming investments would be deployed for both organic and inorganic growth, including opportunities to enter the domestic branded generics market.

PEL highlighted the general operational stability across its sites and the potential business upsides in store amid the overall challenges...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip